About
Circularity Healthcare, LLC is an emerging multinational leader in proprietary circulatory health and non-invasive transdermal technologies focused on boosting blood flow in the body's microcirculatory system with cellular oxygenation and providing unparalleled health and cosmetic outcomes with zero reports of adverse side effects.
Our products are much simpler, faster, and much more affordable than any other conventional or alternative treatment on the market today. D`OXYVA is Circularity's first clinically studied, trademarked and patent-pending transdermal delivery system, which is the latest in the field of microcirculation applications and is named after the two main mechanisms of action related to its solution; deoxyhemoglobin vasodilator.